Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P4HTM | Q9NXG6 | 9/20 | 0.56 |
| ▸ | RAB9A | P51151 | 3/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.50 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.50 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | P4HA1 | P13674 | 1/20 | 0.43 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27193298 | 0.79 | PTPN1 (0.61) | RAB9ASMN1; SMN2PTPN1NPC1TRPV1 | |
| SCHEMBL30828577 | 0.79 | P4HTM (0.72) | P4HTMRAB9ASMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL30828579 | 0.79 | P4HTM (0.72) | P4HTMRAB9ASMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL27193281 | 0.78 | LMNA (0.51) | RAB9ASMN1; SMN2ALDH1A1NPC1KDM4E | |
| SCHEMBL1543044 | 0.72 | PTPN1 (0.70) | P4HTMRAB9ASMN1; SMN2PTPN1PTPN6 | |
| SCHEMBL26885198 | 0.72 | NPC1 (0.66) | RAB9ASMN1; SMN2ALDH1A1NPC1KDM4E | |
| SCHEMBL5934587 | 0.72 | TRPV1 (0.77) | RAB9ANPC1TRPV1 | |
| SCHEMBL26885235 | 0.71 | TRPV1 (0.63) | P4HTMRAB9ASMN1; SMN2PTPN1ALDH1A1 | |
| SCHEMBL7962334 | 0.71 | BAZ2B (0.74) | P4HTMSMN1; SMN2P4HA1BAZ2B | |
| SCHEMBL5934514 | 0.71 | P4HTM (0.61) | P4HTMRAB9ASMN1; SMN2PTPN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240116857-A1 | QUATERNARY AMMONIUM COMPOUNDS AS ANTIMICROBIALS | SAINT LOUIS UNIVERSITY (US) | 2024-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240116857-A1 | QUATERNARY AMMONIUM COMPOUNDS AS ANTIMICROBIALS | ABCC1, ARG1, SLC11A2 | P4HTM 1064/4885RAB9A 1510/4885SMN1; SMN2 4605/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.